Vimarsana
Biggest News Aggregation in the World

Page 2 - Liquidation Preference News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Liquidation Preference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Liquidation Preference Today - Breaking & Trending Today

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred Dividends - Vimarsana News

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred Dividends

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Jan 19, 2024--

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred Dividends - Vimarsana News

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred Dividends

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. are each pleased to announce the declaration of preferred...

Safehold Announces Tax Treatment of 2023 Dividends, Including Pre-Merger Distributions - Vimarsana News

Safehold Announces Tax Treatment of 2023 Dividends, Including Pre-Merger Distributions

NEW YORK, Jan. 8, 2024 /PRNewswire/ -- Safehold Inc. completed a merger with iStar Inc. on March 31, 2023 , in which iStar was the survivor for tax purposes. iStar changed its name to Safehold Inc....

Bellicum Pharmaceuticals : 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 - Form 8-K -December 14, 2023 at 04:41 pm EST - Vimarsana News

Bellicum Pharmaceuticals : 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 - Form 8-K -December 14, 2023 at 04:41 pm EST

Bellicum Pharmaceuticals, Inc. 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 Dear Stockholders of Bellicum Pharmaceuticals, Inc.: ...

Vinci Partners Investments : CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PREFERRED SHARES, PAR VALUE US$0.00005, OF VINCI PARTNERS INVESTMENTS LTD - Form 6-K -October 26, 2023 at 04:23 pm EDT - Vimarsana News

Vinci Partners Investments : CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PREFERRED SHARES, PAR VALUE US$0.00005, OF VINCI PARTNERS INVESTMENTS LTD - Form 6-K -October 26, 2023 at 04:23 pm EDT

CERTIFICATE OF DESIGNATIONS OF SERIES A CONVERTIBLE PREFERRED SHARES, PAR VALUE US$0.00005, OF VINCI PARTNERS INVESTMENTS LTD. ...